Ayurcann Holdings Corp.

CSE:AYUR Canada Healthcare — Drug Manufacturers - Specialty & Generic

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis pr…

Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Transactions 2026-01-30 M&A
Ayurcann Obtains Creditor Protection to Pursue Restructuring and Sales Process
News release - English.pdf
Results 2025-12-01
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697
News release - English.pdf
Results 2025-11-28 Financials
Interim MD&A - English.pdf
Results 2025-11-28 Financials
Interim financial statements/report – English.pdf
News 2025-10-28
News release - English.pdf
Results 2025-10-27 Financials
Annual MD&A - English.pdf
Results 2025-10-27 Financials
Audited annual financial statements – English.pdf

Showing 7 of 17 items in this period.